Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
41 studies found for:    pemphigus
Show Display Options
Rank Status Study
1 Recruiting Study of Efficacy and Safety of VAY736 in Patients With Pemphigus Vulgaris
Condition: Pemphigus Vulgaris
Interventions: Drug: VAY736;   Drug: Placebo to VAY736
2 Recruiting Identification of Vulnerability Factors in the Course of Pemphigus Patients
Conditions: Pemphigus;   Dermatological Disease
Intervention: Behavioral: psychological support and therapeutic education program
3 Active, not recruiting Comparison Between Rituximab Treatment and General Corticotherapy Treatment in Patients With Pemphigus
Condition: Pemphigus Disease
Interventions: Drug: General Corticotherapy;   Drug: Rituximab
4 Unknown  Treatment of Pemphigus Patients With Rituximab 1000mgX2 and Assessment of Immune Status Via Cylex
Condition: Pemphigus
Intervention: Drug: Rituximab
5 Terminated
Has Results
Evaluating Sirolimus to Treat Autoimmune Blistering Dermatosis Pemphigus
Condition: Pemphigus
Intervention: Drug: Sirolimus (formerly known as Rapamycin)
6 Completed Comparison Between Injections of Steroids and Autologous Platelet Rich Plasma in the Oral Erosions of Pemphigus Vulgaris
Condition: Oral Pemphigus Vulgaris
Interventions: Other: Autologous Platelet rich plasma;   Drug: Triamcinolone Acetonide
7 Unknown  Comparative Study of Rituximab Versus Combination of Rituximab and Intravenous Cyclophosphamide in Severe Pemphigus
Condition: Pemphigus
Intervention: Drug: Rituximab and Cyclophosphamide IV
8 Terminated
Has Results
Randomized Trial of IVIg With or Without Cyclophosphamide in Pemphigus
Condition: Pemphigus Vulgaris
Interventions: Drug: intravenous immunoglobulin;   Drug: cyclophosphamide
9 Completed Use of KC706 for the Treatment of Pemphigus Vulgaris
Condition: Pemphigus Vulgaris
Intervention: Drug: KC706
10 Completed
Has Results
Immunoadsorption, Dexamethasone Pulse Therapy and Rituximab for Pemphigus
Condition: Pemphigus
Intervention: Drug: Combination of Protein A Immunoadsorption, Rituximab, Dexamethasone plus Azathioprine
11 Completed Azathioprine Versus Placebo in Pemphigus Vulgaris Treated With Prednisolone
Condition: Pemphigus Vulgaris
Interventions: Drug: Azathioprine;   Drug: Prednisone;   Drug: Placebo
12 Completed Long-term Clinical and Biological Evaluation of Patients With Severe Forms of Pemphigus Treated by Rituximab
Condition: Pemphigus
Intervention: Drug: Rituximab
13 Terminated Long-Term Extension Study of Ofatumumab in Subjects With Pemphigus Vulgaris
Condition: Pemphigus
Interventions: Drug: Ofatumumab;   Drug: Acetaminophen/paracetamol;   Drug: Antihistamine (cetirizine or equivalent);   Drug: Prednisone/Prednisolone
14 Completed Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris
Condition: Pemphigus Vulgaris
Intervention: Drug: Enbrel (Etanercept)
15 Completed Effect of Anti CD20 in Pemphigus Desease
Condition: Pemphigus
Intervention: Drug: Mabthera
16 Completed
Has Results
Use of Infliximab for the Treatment of Pemphigus Vulgaris
Condition: Pemphigus
Interventions: Drug: Infliximab;   Drug: Prednisone;   Other: Placebo
17 Completed European Trial of Adjuvant Oral Glucocorticoid Pulse Therapy in Pemphigus
Condition: Pemphigus
Intervention: Drug: dexamethasone (50mg 1dd6, 3 consecutive days/month)
18 Not yet recruiting A Safety Study of SYNT001 in Subjects With Pemphigus (Vulgaris or Foliaceus)
Conditions: Pemphigus;   Pemphigus Vulgaris;   Pemphigus Foliaceus
Intervention: Drug: SYNT001
19 Terminated Efficacy and Safety of Ofatumumab in Treatment of Pemphigus Vulgaris
Condition: Pemphigus
Interventions: Biological: Ofatumumab;   Biological: Placebo
20 Completed Safety Study of PI-0824 to Treat Pemphigus Vulgaris
Condition: Pemphigus Vulgaris
Intervention: Drug: PI-0824

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.